Ezeprogind

DB16954InvestigationalSmall molecule

Ezeprogind: Overview.

Chemical structure of Ezeprogind
Mechanism
Curator reviewed
Formula / weight
C25H44N6 · 428.669 g/mol (avg)
Also known as
1,4-piperazinedipropanamine, n'-1h-benzimidazol-2-yl-n,n-bis(2-methylpropyl)- · 1,4-piperazinedipropanamine, n4-1h-benzimidazol-2-yl-n1,n1-bis(2-methylpropyl)- · Azp-2006 free base · Azp2006 free base · N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo(d)imidazol-2-amine

Resolves to

Compound
UNIITR9YQ07ELNCAS615539-20-3ChEMBLCHEMBL419432
Structure
InChIKeyKLKKWCPJBTXWOV-UHFFFAOYSA-NSMILESCC(C)CN(CCCN1CCN(CCCNC2=NC3=CC=CC=C3N2)CC1)CC(C)C
Targets
Q9NR96TLR9P07602PSAP

What you can answer from here — as of August 30, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Ezeprogind, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In